A股異動 | 大立科技逆勢升6.54%有望再創新高 年度淨利大增146%
格隆匯2月28日丨大立科技(002214.SZ)近期走勢強勁,昨日新高後收盤迴落。今日再次強勢上漲,現升6.54%有望再創新高,報24.93元,暫成交17億元,最新總市值114.35億元,大立科技昨日公告,2019年度淨利潤升146.11%至1.35億元。公司前期多種已定型軍品型號生產任務全面恢復,實現批量交付,多個項目開始規模化貢獻業績。隨着新冠肺炎疫情的蔓延,紅外熱成像體温檢測設備的銷量一路高漲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.